Navigation Links
Enzyme supply may improve Alzheimer’s condition.

A pioneering drug treatment has revealed that memory function can be restored in mice afflicted with Alzheimer’s disease.//

Dr. Michael Shelanski, director of the Alzheimer's Research Center at Columbia University and his colleagues carried out this study. They treated mice whose brains were already clogged with the amyloid plaques. These plaques are responsible for the irreversible brain damage characteristic of the disease. The same drug may, sometime in future, treat humans with late-stage Alzheimer’s.

Destruction of the plaques and prevention of new ones from forming, are the areas where already existing treatments and vaccines work. This recent treatment aims at a different part of the brain and is effective irrespective of the presence or absence of the plaques. The idea is to help brain cells remove unwanted or over-abundant proteins.

There's no way to know if the approach will work in humans, but researchers are hopeful. In essence, "we were able to restart -- or make more efficient -- the garbage disposal function of the cell," said Dr. Shelanski.

The amyloid beta plaque protein, which is abundant in people with Alzheimer’s, when comes in contact with healthy brain cells results in a decrease of the enzyme responsible for protein disposal called ubiquitin C-terminal hydrolase L1 (Uch-L1).

This results in disruption of protein disposal and hence, they got accumulated in the brain cells of the Alzheimer’s patient.

The team provided extra supplies of the missing enzyme to both brain tissues grown in the lab and to mice with the equivalent of Alzheimer’s disease and studied its effect.

Exposure of healthy brain cells to amyloid beta protein results in disruption of neurotransmission. This condition was reversed by the extra supply of the enzyme Uch-L1. This was tested on mice with the rodent equivalent of Alzheimer’s disease. When the enzyme was supplied to the mice through an injecti on into the abdomen, their memory improved markedly in spite of the presence of plaques.

“We’re hoping that this treatment can help people who have a lot of plaques in their brain already, or perhaps in combination with other compounds that reduce amyloid-beta,” says Shelanski.

But he says that the route of supplying the enzyme is “not ideal”. They are screening several molecules that would enhance the enzyme level and could be given as a pill.

“The approach might work best in people whose brains still contain soluble rather than solid deposits of amyloid beta protein, as disruption of memory formation by the soluble form is reversible”, comments Brian Austen, who studies amyloid protein at St George’s University of London, UK.

“But brain cells damaged by the solid plaque might not be recoverable”, Austen says. “The approach would not help patients get back their missing neurones, but it would prevent any further memory loss.”

The possibility of a potential new drug and new target for Alzheimer’s treatment was acknowledged by the UK Alzheimer’s Society. “Currently, there’s only one type of drug available, and this only stabilises symptoms for a limited period,” said a spokeswoman. “But research on the new approach is still in the early stages [...] so further trials and researchare urgently needed.”
'"/>




Related medicine news :

1. Enzyme may be target for obesity drugs
2. Researchers trick Alzheimers Enzyme
3. Enzyme stimulates growth of adult stem cells
4. Enzyme may aid hold back disease
5. Enzyme help destroy cancer cell
6. Enzyme Associated with Memory
7. Enzyme Associated With Memory
8. Brain Enzyme Found To Regulate Weight
9. New Enzyme Identified For Arthritis
10. Enzyme for treatment of arthritis
11. An Enzyme That Turns a One –time Experience into a long-time Memor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... PLAINSBORO, N.J. (PRWEB) , ... June 27, 2016 , ... ... same sources, yet in many ways they remain in the eye of the beholder, ... Oncology (EBO), a publication of The American Journal of Managed Care. For the full ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... NAMUR , Belgium , ...  (NYSE MKT: VNRX), today announced the appointment of ... Board of Directors as a Non-Executive Director, effective ... the Company,s Audit, Compensation and Nominations and Governance ... Board, Dr. Futcher will provide independent expertise and ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
Breaking Medicine Technology: